Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

AstraZeneca ties up with France’s Transgene to develop viral immunotherapies

British drugmaker AstraZeneca Plc and French biopharmaceutical firm Transgene SA entered into an agreement to jointly develop five cancer-killing viral immunotherapies.

Read More »

Dragonfly and Merck Strike Deal for Solid Tumors

Waltham, Mass.-based Dragonfly Therapeutics struck a licensing agreement worth up to $695 million with Merck, which will license exclusive rights to Dragonfly’s TriNKET technology platform for a number of solid-tumor programs.

Read More »

Novartis strikes deal with Chinese firm to make Kymriah

Chinese manufacturer Cellular Biomedicine has been enlisted to make Novartis’ $475,000 gene-modifying cancer treatment Kymriah as the Swiss drugmaker intends to win approval for the therapy in the world’s most populous country.

Read More »

U.S. House committee ‘may reconsider’ WHO cancer agency funds

U.S. congressional committee members warned that Washington’s funding of the World Health Organization’s cancer research agency could be halted unless it is more open about its operations.

Read More »

China launches pollution probe after hundreds of students fall sick

Authorities in China have launched an investigation after a report that hundreds of children attending a language school built near a polluted former industrial site developed health problems, including cancer, state news agency Xinhua reported on Monday. The municipal government of Changzhou, about 100 km (60 miles) northwest of Shanghai, said that since December students […]

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!

Subscribe

Ad Right Bottom